SUNNYVALE, Calif.--(BUSINESS WIRE)--July 26, 2006--IntraOp Medical Corporation (OTCBB: IOPM - News) has received an order for its first Mobetron System in China. It will be the fourth Mobetron acquired by a hospital in Asia, and the 19th worldwide. The Mobetron is an FDA-approved, easily transportable electron-beam instrument designed for intraoperative electron radiation therapy (IOERT), or the direct application of radiation to a tumor while a patient is undergoing cancer surgery. This first Chinese order will be installed at Beijing Tumor Hospital, China's premier cancer research and treatment center, often called the "National Cancer Institute of China," and a part of Beijing University Medical Center. In addition to treating patients, the hospital will use the Mobetron to train other Chinese practitioners in the use of IOERT and develop and expand the use of IOERT throughout China.
